Unlock stock picks and a broker-level newsfeed that powers Wall Street.
5.86
-0.46
(-7.27%)
At close: April 4 at 8:08:56 PM GMT+2
Loading Chart for UR9.MU
- Previous Close
6.32 - Open
6.03 - Bid 5.66 x --
- Ask 5.86 x --
- Day's Range
5.86 - 6.03 - 52 Week Range
5.86 - 10.74 - Volume
170 - Avg. Volume
156 - Market Cap (intraday)
885.163M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: UR9.MU
View MorePerformance Overview: UR9.MU
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
UR9.MU
17.57%
S&P/ASX 200 [XJO] (^AXJO)
6.02%
1-Year Return
UR9.MU
39.05%
S&P/ASX 200 [XJO] (^AXJO)
1.36%
3-Year Return
UR9.MU
51.75%
S&P/ASX 200 [XJO] (^AXJO)
2.05%
5-Year Return
UR9.MU
43.26%
S&P/ASX 200 [XJO] (^AXJO)
51.31%
Compare To: UR9.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UR9.MU
View MoreValuation Measures
As of 4/4/2025
Market Cap
302.09M
Enterprise Value
189.01M
Trailing P/E
13.37
Forward P/E
13.46
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.64
Price/Book (mrq)
2.36
Enterprise Value/Revenue
3.61
Enterprise Value/EBITDA
5.21
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: UR9.MU
View MoreCompany Insights: UR9.MU
Research Reports: UR9.MU
View MorePeople Also Watch
UR9.F Clinuvel Pharmaceuticals Limited
5.81
-10.62%
UP0.F Ultragenyx Pharmaceutical Inc.
31.40
0.00%
DR6.F ACADIA Pharmaceuticals Inc.
14.41
-2.31%
SMZ1.SG Sino Biopharmaceutical Limited
0.4391
-1.15%
SMZ1.F Sino Biopharmaceutical Limited
0.4430
-1.56%
KK3A.F Cytokinetics, Incorporated
33.80
-8.15%
2L9.F Blueprint Medicines Corporation
75.60
-3.10%
4DN.MU Denali Therapeutics Inc.
11.63
-4.16%
AM6.F Amicus Therapeutics, Inc.
7.15
+1.42%
4DN.F Denali Therapeutics Inc.
11.71
-4.64%
GXEA.F Galapagos NV
21.60
-1.82%
4AJ0.F ALK-Abelló A/S
18.82
+1.67%
GLPG.VI Galapagos NV
21.80
-0.64%
UTH.F United Therapeutics Corporation
275.90
+1.77%
NKB2.F TG Therapeutics, Inc.
35.07
-1.21%
J7Z.F Jazz Pharmaceuticals plc
100.50
-8.39%